back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-04-01 12:43 Tx date 2026-03-31 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+29,207 vol |
317,707 | |
| Older filings | ||||||
| Filed 2026-03-03 11:23 Tx date 2026-03-02 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,191 vol |
288,500 | |
| Filed 2026-02-24 15:48 Tx date 2026-02-19 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+27,285 vol |
287,309 | |
| Filed 2026-02-24 15:47 Tx date 2026-02-19 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,996
+2,450 vol $4.08 each |
260,024 | |
| Filed 2026-02-24 15:46 Tx date 2026-02-19 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-9,996
-2,450 vol $4.08 each |
779,330 | |
| Filed 2026-02-02 15:47 Tx date 2026-02-02 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,558 vol |
257,574 | |
| Filed 2026-01-16 12:59 Tx date 2026-01-14 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,500
+10,000 vol $2.45 each |
256,016 | |
| Filed 2026-01-16 12:58 Tx date 2026-01-15 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-24,500
-10,000 vol $2.45 each |
781,780 | |
| Filed 2026-01-08 10:13 Tx date 2026-01-07 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$34,750
+14,184 vol $2.45 each |
246,016 | |
| Filed 2026-01-08 10:12 Tx date 2026-01-07 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-34,750.80
-14,184 vol $2.45 each |
791,780 | |
| Filed 2026-01-05 12:29 Tx date 2026-01-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,382 vol |
231,832 | |
| Filed 2025-12-03 16:40 Tx date 2025-12-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,430 vol |
230,450 | |
| Filed 2025-11-06 17:55 Tx date 2025-11-03 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,430 vol |
228,020 | |
| Filed 2025-10-02 08:57 Tx date 2025-10-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,430 vol |
225,590 | |
| Filed 2025-09-04 07:35 Tx date 2025-09-02 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,431 vol |
223,160 | |
| Filed 2025-08-04 10:55 Tx date 2025-08-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,431 vol |
220,729 | |
| Filed 2025-07-02 09:01 Tx date 2025-07-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,431 vol |
218,298 | |
| Filed 2025-06-04 13:07 Tx date 2025-06-02 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$41,922
+8,220 vol $5.10 each |
215,867 | |
| Filed 2025-06-04 13:05 Tx date 2025-06-02 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-41,922
-8,220 vol $5.10 each |
805,964 | |
| Filed 2025-06-04 13:03 Tx date 2025-06-02 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,431 vol |
207,647 | |